How many clinical trials are there for SF3B1 Gene Mutation?

PlainTrial tracks 1 US clinical trials for SF3B1 Gene Mutation, of which 0 are currently recruiting.

Which interventions appear most often on SF3B1 Gene Mutation trial records?

Recommendation for treatment with immunotherapy is the most-linked intervention name on SF3B1 Gene Mutation records (1 trial links). Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for SF3B1 Gene Mutation?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

SF3B1 Gene Mutation clinical trials

Compiled by PlainTrial · August 8, 2026

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Browse conditions → How counts are built

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

SF3B1 Gene Mutation: 1 US clinical trial tracked, none currently recruiting.

SF3B1 Gene Mutation is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, running 1 of these trials.

Enrollment posture brief

Registry condition sf3b1-gene-mutation

Volume-matched condition peers

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Open-enrollment share among volume-matched conditions near SF3B1 Gene Mutation

SF3B1 Gene Mutation has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for SF3B1 Gene Mutation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

SF3B1 Gene Mutation is recruiting below its size-band peers.

0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Indexed trials (enrollment closed)

1 total, page 1 of 1

ACTIVE NOT RECRUITING 6 participants

Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

NCT04447651

Phase Distribution

Phase data not available

Top Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 trials

Named interventions

Most-linked intervention names on SF3B1 Gene Mutation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Recommendation for treatment with immunotherapy Other

1 trials

US sites by state

Facility locations filed on SF3B1 Gene Mutation trials. A trial with sites in several states counts in each.

Maryland 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this SF3B1 Gene Mutation page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

No SF3B1 Gene Mutation trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins sponsors the most SF3B1 Gene Mutation trials on record, review their full trial history before evaluating a specific study. See Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This SF3B1 Gene Mutation condition card totals 1 registered trials; most-linked intervention Recommendation for treatment with immunotherapy; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.